CPI-455
-
- Application
- Inhibition (Inh)
- Purpose
- Lysine demethylase KDM5 inhibitor
- Characteristics
- CPI-455 (1628208-23-0) is a potent (IC50 = 10 nM) and selective inhibitor of the lysine demethylase KDM5 (equal inhibition of KDM5A, 5B, 5C). CPI-455 reduced the number of drug-tolerant persister cancer cells (DTPs) in a dose-dependent, KDM5-dependent manner in multiple cell lines treated with standard chemotherapy or targeted agents. CPI-455 synergized with 5-aza-2'-deoxycytidine (DAC) to reduce the viability of luminal breast cancer cells in vitro. KDM5 demethylases have recently been shown to repress the immune response to tumors via suppression of STING.
- Purity
- >98 %
- Chemical Name
- 7-Oxo-5-phenyl-6-propan-2-yl-1H-pyrazolo[1,5-a]pyrimidine-3-carbonitrile
- Formula
- C16H14N4O
- Solubility
- Soluble in DMSO (up to at least 25 mg/ml)
-
-
- Restrictions
- For Research Use only
-
- Format
- Powder
- Storage
- -20 °C
-
- Background
- Epigenetics,Chromatin,Protein demethylase,STING,Immunology,Cancer,Posttranslational modification,Cytokine
- Molecular Weight
- 278.32
- CAS-No
- 1628208-23-0
-